Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ-0,31
KB-0,33
PKN103,7103,960,25
Msft504,45504,52-1,31
Nokia5,9846,084-0,33
IBM306,07306,33-2,77
Mercedes-Benz Group AG59,859,820,59
PFE25,8625,87-0,01
13.11.2025 20:32:00
Indexy online
AD Index online
select
AD Index online
 

  • 13.11.2025 20:27:40
Omnicell Inc (OMCL.O, NASDAQ Cons)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (USD)
36,09 -2,09 -0,77 4 223 433
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace:
Popis společnosti
Obecné informace
Název společnostiOmnicell Inc
TickerOMCL
Kmenové akcie:Ordinary Shares
RICOMCL.O
ISIN-
Poslední známé roční výsledky31.12.2024
Poslední známé čtvrtletní výsledky30.09.2025
Počet zaměstnanců k 30.09.2025 3 600
Akcie v oběhu k 30.09.2025 44 876 000
MěnaUSD
Konstituent indexůS&P 600 Small Cap
Kontaktní informace
Ulice4220 NORTH FREEWAY
MěstoFORT WORTH
PSČ76137
ZeměUnited States
Kontatní osobaKathleen Nemeth
Funkce kontaktní osobyInvestor Relations
Telefon16 502 516 100
Fax16502516266

Business Summary: Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company’s XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Omnicell Inc revenues increased 8% to $870.9M. Net income totaled $4.1M vs. loss of $3.3M. Revenues reflect Services and other revenues segment increase of 8% to $411.3M, Hardware and software segment increase of 8% to $192.4M, United States segment increase of 8% to $790.9M, Rest of the World segment increase of 9% to $80M.
Odvětvová klasifikace
TRBC2009Healthcare Facilities / Services
TRBC2012Medical Software & Technology Services
RBSS2004Healthcare Facilities
MGINDUSTRYSoftware & Programming
MGSECTORTechnology
NAICSCustom Computer Programming Services
NAICSSoftware Publishers
NAICSComputing Infrastructure Providers, Data Processing, Web Hosting, and Related Services
NAICS2007Custom Computer Programming Services
NAICS2007Software Publishers
NAICS2007Data Processing, Hosting, and Related Services
NAICS1997Custom Computer Programming Services
NAICS1997Software Publishers
NAICS1997Data Processing Services
SICElectronic Computers
SICComputer Programming Services
SICPrepackaged Software
SICData Processing And Preparation



  • Poslední aktualizace:
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Board, President, Chief Executive OfficerRandall Lipps6716.10.2002
Chief Financial Officer, Executive Vice PresidentBaird Radford5526.08.202526.08.2025
Chief Operating Officer, Executive Vice PresidentNnamdi Njoku4807.10.202407.10.2024
Executive Vice President, Chief Legal and Administrative OfficerCorey Manley47